Information
Glenmark Pharmaceuticals Inc. Recalls Nebivolol Tablets
This is a Class III recall. This product is unlikely to cause adverse health reactions but violates FDA regulations.
Source: FDA
InfoRecall #D-0222-2026Drug / Pharmaceutical
Glenmark Pharmaceuticals Inc. Recalls Nebivolol Tablets
Glenmark Pharmaceuticals Inc., USA · Class III — Regulatory
Product Description
Nebivolol Tablets, 20 mg, 90 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for Avkare, Pulaski, TN 38478, Product of Italy, NDC 42291-874-90.
Reason for Recall
Cross Contamination with Other Products
FDA Classification
Class III — Regulatory
A situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Distribution
U.S. Nationwide
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
The FDA has classified this as a Class III recall — the lowest severity level — for a pharmaceutical product recalled by Glenmark Pharmaceuticals Inc., USA on November 18, 2025. Cross Contamination with Other Products. This recall covers 672 90-count bottles, distributed in U.S. Nationwide. Class III recalls typically involve products unlikely to cause health problems but that violate FDA manufacturing or labeling regulations.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medical Product Contamination.